- Home
- MRNA vs NYT Comparison
MRNA vs NYT Comparison
Compare MRNA & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | NYT |
|---|---|---|
| Founded | 2010 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.5B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRNA | NYT |
|---|---|---|
| Price | $55.54 | $81.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $33.00 | ★ $67.33 |
| AVG Volume (30 Days) | ★ 9.6M | 2.5M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | ★ 21.77 | 18.08 |
| EPS | N/A | ★ 2.09 |
| Revenue | ★ $19,263,000,000.00 | $1,783,639,000.00 |
| Revenue This Year | $8.28 | $10.40 |
| Revenue Next Year | $16.53 | $6.35 |
| P/E Ratio | ★ N/A | $38.33 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $44.83 |
| 52 Week High | $59.55 | $82.74 |
Technical Indicators
Market Signals| Indicator | MRNA | NYT |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 65.88 |
| Support Level | $23.74 | $69.30 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 3.84 | 2.21 |
| MACD | 0.26 | 0.33 |
| Stochastic Oscillator | 69.97 | 80.34 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.